WallStSmart

Salesforce.com Inc (CRM)vsMarti Technologies Inc. (MRT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 87943% more annual revenue ($42.83B vs $48.65M). CRM leads profitability with a 18.7% profit margin vs -79.8%. CRM earns a higher WallStSmart Score of 76/100 (B+).

CRM

Strong Buy

76

out of 100

Grade: B+

Growth: 7.3Profit: 7.5Value: 8.0Quality: 4.5
Piotroski: 5/9Altman Z: 1.50

MRT

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 4.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: -10.06
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRMUndervalued (+78.9%)

Margin of Safety

+78.9%

Fair Value

$720.27

Current Price

$185.66

$534.61 discount

UndervaluedFair: $720.27Overvalued
MRTOvervalued (-6.7%)

Margin of Safety

-6.7%

Fair Value

$1.94

Current Price

$1.80

$0.14 premium

UndervaluedFair: $1.94Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRM6 strengths · Avg: 8.7/10
EPS GrowthGrowth
52.2%10/10

Earnings expanding 52.2% YoY

Market CapQuality
$134.77B9/10

Large-cap with strong market position

Return on EquityProfitability
23.4%9/10

Every $100 of equity generates 23 in profit

PEG RatioValuation
0.798/10

Growing faster than its price suggests

Operating MarginProfitability
21.8%8/10

Strong operational efficiency at 21.8%

Free Cash FlowQuality
$6.56B8/10

Generating 6.6B in free cash flow

MRT3 strengths · Avg: 10.0/10
Return on EquityProfitability
85.4%10/10

Every $100 of equity generates 85 in profit

Revenue GrowthGrowth
156.1%10/10

Revenue surging 156.1% year-over-year

Debt/EquityHealth
-1.2210/10

Conservative balance sheet, low leverage

Areas to Watch

CRM2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

Debt/EquityHealth
1.223/10

Elevated debt levels

MRT4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$151.26M3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-5.79M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
-10.062/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CRM

The strongest argument for CRM centers on EPS Growth, Market Cap, Return on Equity. Profitability is solid with margins at 18.7% and operating margin at 21.8%. Revenue growth of 13.3% demonstrates continued momentum.

Bull Case : MRT

The strongest argument for MRT centers on Return on Equity, Revenue Growth, Debt/Equity. Revenue growth of 156.1% demonstrates continued momentum.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score, Debt/Equity.

Bear Case : MRT

The primary concerns for MRT are EPS Growth, Market Cap, Free Cash Flow.

Key Dynamics to Monitor

CRM profiles as a mature stock while MRT is a hypergrowth play — different risk/reward profiles.

CRM carries more volatility with a beta of 1.15 — expect wider price swings.

MRT is growing revenue faster at 156.1% — sustainability is the question.

CRM generates stronger free cash flow (6.6B), providing more financial flexibility.

Bottom Line

CRM scores higher overall (76/100 vs 36/100), backed by strong 18.7% margins and 13.3% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Marti Technologies Inc.

TECHNOLOGY · SOFTWARE - APPLICATION · USA

MedEquities Realty Trust, Inc. (the?

Want to dig deeper into these stocks?